Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 11;50(16):3696-700.
doi: 10.1002/anie.201008277. Epub 2011 Mar 17.

Phosphorescent nanoscale coordination polymers as contrast agents for optical imaging

Affiliations

Phosphorescent nanoscale coordination polymers as contrast agents for optical imaging

Demin Liu et al. Angew Chem Int Ed Engl. .

Abstract

Optical imaging, which uses neither ionizing radiation (as in X-ray computed tomography) nor radioactive materials (as in positron emission tomography or single photon emission computed tomography),[1] has emerged as a powerful imaging modality during the last two decades.[2] Optical imaging has been widely employed for oncological and other applications due to its ability to noninvasively differentiate between diseased (e.g., tumor) and healthy tissues based on differential dye accumulations.[3] The need for relatively high (up to ~µM) concentrations of dyes in optical imaging, however, limits its application in many areas, such as detecting low concentrations of biological targets. For example, many biomarkers are overexpressed in the nM concentrations in diseased tissues,[4] and cannot be readily visualized by optical imaging. Dye-loaded nanoparticles represent a logical solution to lowering the detection limit due to their ability to carry a large payload of dye molecules as well as to target certain cell types by conjugation to affinity molecules. Luminescent quantum dots have indeed been extensively explored as bright and stable contrast agents for optical imaging.[5] The non-degradable nature of and the use of toxic elements in many quantum dot formulations however limit their applications in many areas. Most of fluorescent dye molecules, on the other hand, have small Stokes shifts and tend to have a significant overlap between absorption and fluorescent emission spectra. As a result, these fluorescence dyes will suffer from severe self-quenching if they are brought into close proximity with each other, as in nanoparticles with high dye loadings.

PubMed Disclaimer

Figures

Figure 1
Figure 1
a) A top view of the 2D layer of 1 down the b axis; b) A side view along the a axis showing the packing of the 2D layers in 1; c) SEM image of NCP-1; d) Absorption [1] and emission [2] spectra of NCP-1 in ethanol. The absorption spectrum of dissolved NCP-1 [3] was also taken to eliminate the scattering effects.
Figure 2
Figure 2
SEM and TEM (inset) images of NCP-2 (a), SiO2@2 (b), and AA-PEG-SiO2@2 (c); d) Number-averaged size distribution for NCP-2 (open circle), SiO2@2 (solid circle), PEG-SiO2@2 (open triangle), and AA-PEG-SiO2@2 (solid triangle) in ethanol; e) Absorption and emission spectra: abs. spec. for NCP-2 [1], Abs. Spec. for AA-PEG-SiO2@2 [2], abs. spec. for NCP-2 after digestion [3], Abs. Spec. for AA-PEG-SiO2@2 after digestion [4], normalized emiss. spec. for NCP-2 [5], normalized emiss. spec. for AA-PEG-SiO2@2 [6]; f) Release profiles of NCP-2 (triangle) and SiO2@2 (sqaure) in 8 mM PBS at 37 °C.
Figure 3
Figure 3
Confocal microscopic images of H460 cells that have been incubated with various nanoparticles: control cells without any particles (a), cells with PEG-SiO2@2 (b), and cells with AA-PEG-SiO2@2 (c); d) in vitro viability assay for H460 cells incubated with various amounts of PEG-SiO2@2 and AA-PEG-SiO2@2; e) Particle uptake studies in H460 cells.
Scheme 1
Scheme 1
Synthesis of NCP-2, and coating of NCP-2 with a thin shell of silica, and further functionalization of SiO2@2 with PEG and PEG-anisamide.

References

    1. Fujimoto J, Farkas D. Biomedical Optical Imaging. First ed. New York: Oxford University Press, Inc.; 2009.
    1. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Nat. Biotech. 2005;23:313. - PubMed
    2. Kobayashi H, Ogawa M, Alford R, Choyke PL, Urano Y. Chem. Rev. 2009;110:2620. - PMC - PubMed
    3. Kim C, Favazza C, Wang LV. Chem. Rev. 2010;110:2756. - PMC - PubMed
    1. Nahrendorf M, Keliher E, Marinelli B, Waterman P, Feruglio PF, Fexon L, Pivovarov M, Swirski FK, Pittet MJ, Vinegoni C, Weissleder R. Proc. Natl. Acad. Sci. 2010;107:7910. - PMC - PubMed
    2. Cobley CM, Chen J, Cho EC, Wang LV, Xia Y. Chem. Soc. Rev. 2011;40:44. - PubMed
    3. Nam T, Park S, Lee SY, Park K, Choi K, Song IC, Han MH, Leary JJ, Yuk SA, Kwon IC, Kim K, Jeong SY. Bioconjug. Chem. 2010;21:578. - PubMed
    1. Kikuchi K. Chem. Soc. Rev. 2010;39:2048. - PubMed
    2. Cheng MMC, Cuda G, Bunimovich YL, Gaspari M, Heath JR, Hill HD, Mirkin CA, Nijdam AJ, Terracciano R, Thundat T, Ferrari M. Curr. Opin. Chem. Biol. 2006;10:11. - PubMed
    3. Haruyama T. Adv. Drug Del. Rev. 2003;55:393. - PubMed
    1. Alivisatos P. Nat. Biotechnol. 2004;22:47. - PubMed
    2. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S. Curr. Opin. Biotechnol. 2005;16:63. - PubMed
    3. Somers RC, Bawendi MG, Nocera DG. Chem. Soc. Rev. 2007;36:579. - PubMed

Publication types